Impact of the COVID-19 pandemic on the quality of life of early breast cancer patients undergoing adjuvant chemotherapy – an observational, multicenter study
The well-being of breast cancer patients during the chemotherapy treatment in the pandemic era was moderately better than in the pre-pandemic era. Patients in the pandemic era might have reported fewer symptoms during the treatment, as the focus was on the COVID-19 pandemic and its restrictions.
Authors
- Ilja Kalashnikov (ORCID: https://orcid.org/0000-0002-6593-3907)
- Paula Poikonen‐Saksela (ORCID: https://orcid.org/0000-0003-2274-1937)
- Arja Jukkola‐Vuorinen (ORCID: https://orcid.org/0000-0002-6107-1764)
- Päivi Auvinen (ORCID: https://orcid.org/0000-0002-2392-9395)
- Jussi Pekka Koivunen (ORCID: https://orcid.org/0000-0001-6425-1640)
- Peeter Karihtala (ORCID: https://orcid.org/0000-0003-3490-3702)
- Okko‐Sakari Kääriäinen (ORCID: https://orcid.org/0000-0002-2905-6310)
- Kaisa Sunela (ORCID: https://orcid.org/0000-0002-2639-5448)
- Sirpa Leppä (ORCID: https://orcid.org/0000-0002-8265-511X)
- Marie Tuomarila
- Johanna Mattson (ORCID: https://orcid.org/0000-0002-9719-9110)
- Meri Utriainen (ORCID: https://orcid.org/0000-0002-6727-2268)
- Haridimos Kondylakis (ORCID: https://orcid.org/0000-0002-9917-4486)
- Pia Vihinen (ORCID: https://orcid.org/0000-0003-1763-5363)
Institutions
- University of Helsinki (FI)
- Oulu University Hospital (FI)
- Helsinki University Hospital (FI)
- Turku University Hospital (FI)
- Kuopio University Hospital (FI)
- Turku PET Centre (FI)
- Tampere University Hospital (FI)
- Tampere University (FI)
- Foundation for Research and Technology Hellas (GR)
Publication Details
- Journal
- Acta Oncologica
- Published
- 2025-10-08
- DOI
- https://doi.org/10.2340/1651-226x.2025.43691
- Primary Topic
- Cancer survivorship and care
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Commission
- European Regional Development Fund